Sign in Subscribe
Pharmaceutical industry

Global H1N1 Vaccines Market Analysis and Forecasts

Strategic Insights

— 1 min read

The global H1N1 vaccines market experienced significant growth in 2009 and 2010 due to the pandemic outbreak. The market was driven by government initiatives to develop and distribute vaccines, as well as increased demand for infection prevention and control measures. Major companies such as Baxter International, Novartis, and Sanofi Pasteur developed and marketed H1N1 vaccines, with some receiving regulatory approvals from global health organizations like the WHO.

Key Takeaways:

  • The global H1N1 vaccines market was valued at $1.4 billion in 2009 and is expected to reach $2.5 billion by 2015, growing at a CAGR of 10.2%.
  • Baxter International, Novartis, and Sanofi Pasteur were among the top companies to develop and market H1N1 vaccines.
  • The US government allocated $1 billion for the development of H1N1 vaccines, with some companies receiving approval for their products.
  • Panenza (Sanofi Pasteur), Celtura (Novartis), and Fluvirin (Novartis) were among the top H1N1 vaccines available in the market.
  • The market in the Asia-Pacific region accounted for approximately 30% of the global market share in 2010, with countries such as India and China being major contributors.
  • The use of cell culture-based technology and egg-based production process were major focus areas for companies developing H1N1 vaccines.
  • The market for H1N1 vaccines is expected to decline gradually as the pandemic outbreak subsides, but the demand for pandemic influenza vaccines is expected to be sustained in the long term.

Statistics:

  • Global H1N1 vaccines market size: $1.4 billion in 2009 and $2.5 billion by 2015, growing at a CAGR of 10.2%.
  • Baxter International's H1N1 vaccine sales in 2009: $600 million.
  • Novartis' H1N1 vaccine sales in 2009: $400 million.
  • Sanofi Pasteur's H1N1 vaccine sales in 2009: $300 million.
  • Number of H1N1 cases worldwide: 200,000 in 2009 (WHO).
  • Number of H1N1 deaths worldwide: 18,500 in 2009 (WHO).
  • Global H1N1 market share by region: Asia-Pacific (30%), Europe (25%), North America (20%), and Rest of World (25%).

Sources:

  • Reportlinker (New York) - "H1N1 Vaccines: A Weapon to Combat the New Flu Virus"
  • Baxter International, Inc. (US) - "H1N1 Vaccines"
  • Novartis AG (Switzerland) - "Celtura (H1N1) Vaccine"
  • Sanofi Pasteur, SA (France) - "Panenza (H1N1) Vaccine"
  • WHO (World Health Organization) - "H1N1 Pandemic Situation"

Read more